Latest News about JNJ
Recent news which mentions JNJ
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push
September 15, 2021
From MarketWatch
7 Great Stocks to Buy for an Income-Rich Retirement
September 14, 2021
From InvestorPlace
Novavax Has More Room to Run as the Vaccination Push Carries On
September 14, 2021
From InvestorPlace
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
September 14, 2021
From Benzinga
‘Shoulda Got the Shot’: New PSAs employ real people rather than science and data to encourage unvaccinated Americans to change their minds
September 14, 2021
From MarketWatch
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
G Medical Innovations: The Next Generation of Healthcare for Caregivers and Patients
September 13, 2021
From Benzinga
Will Pfizer's COVID Vaccine Marketing Push Pay Off?
September 12, 2021
From Motley Fool
3 Dividend Stocks to Buy and Hold Forever
September 12, 2021
From Motley Fool
3 Dividend Investing Tips That Could Earn You Thousands
September 11, 2021
From Motley Fool
5 of the Safest Dividend Stocks Retirees Can Buy Right Now
September 11, 2021
From Motley Fool
From MarketWatch
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
From Benzinga
You ought to favor large-cap stocks through the end of the year
September 10, 2021
From MarketWatch
Endo Shares Move Higher On Settlement Of New York State Opioid Cases
September 10, 2021
From Benzinga
Could This Be Pfizer's Next Blockbuster Vaccine?
September 10, 2021
From Motley Fool
Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders?
September 10, 2021
Tickers
JNJ
From Motley Fool
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
September 10, 2021
From Motley Fool
Coca-Cola And Merck Lead The Dow Jones Lower
September 09, 2021
From Benzinga
Why Shares of Johnson & Johnson Are Down 2% Today
September 09, 2021
From Motley Fool
This Controversial Move Could Save Johnson & Johnson Billions
September 09, 2021
Tickers
JNJ
From Motley Fool
EMA To Add New Side Effects To Janssen, AstraZeneca COVID-19 Shots
September 08, 2021
From Benzinga
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
Johnson & Johnson's Prostate Cancer Drug Erleada Wins NICE Approval
September 08, 2021
Tickers
JNJ
From Benzinga
Downgrades On Economy And Pandemic Pharmaceuticals
September 08, 2021
From Benzinga
From Benzinga
Vaxart Stock Is One Vaccine Also-Ran Worth Another Look
September 08, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.